Satellite Healthcare Announces Recipients of 2010 Norman S. Coplon Extramural Grants
Mountain View, CA, September 13, 2010 –– Satellite Healthcare, one of the nation’s first and leading not-for-profit kidney dialysis service providers and a major sponsor of nephrology research, is pleased to announce the recipients of the 2010 Norman S. Coplon Extramural Grants. Each year Satellite Healthcare awards the grants, which total up to $150,000 over three years, to promising early-career researchers dedicated to undertaking critical research in the area of kidney disease and its treatment.
The Coplon Grants Program, named after Satellite Healthcare founder Norman Coplon, is funded by one of the country’s largest private endowments for research into kidney disease and its treatment, and supports both bench (i.e., “basic science”) research as well as applied science research. A highlight of the program is an Annual Symposium which provides a forum for recipients at all stages in their projects to share their findings with peers and members of Satellite Healthcare’s Scientific Advisory Board, receive constructive feedback, and participate in an open exchange of ideas.
Dr. Brigitte Schiller, Chief Medical Officer of Satellite Healthcare, was remarkably pleased with this year’s pool of applicants. “The quality of the grant applications was outstanding. Selecting the winners was no easy task, and I could not be more impressed by the diverse group of researchers the Scientific Advisory Board ultimately chose,” she said. “It gives me great pride to witness our grant recipients continue the program’s strong tradition of conducting innovative and important kidney disease research.”
The recipients, who hail from across North America, include:
- Hui Cai, MD, Emory University School of Medicine
“The Role of a Novel MNK Signaling Pathway in Sodium Chloride Cotransporter (NCC) Regulation”
- Julie Ho, MD, University of Manitoba
“Novel Urine Biomarkers of Progressive Interstitial Fibrosis/Tubular Atrophy and Renal Allograft
- Shuta Ishibe, MD, Yale University School of Medicine
“The Role of Synaptojanin-1 in Podocyte Homeostasis”
- Darius Mason, Pharm.D., BCPS, Albany College of Pharmacy and Health Sciences
“Sustainability of Serum [250HD] Levels, Inflammatory Reduction, and Endothelial Dysfunction after
Repletion with Ergocalciferol in CKD Stage 5D”
- Anne Murray, MD, Minneapolis Medical Research Foundation
“Decline in Physical Function and Independence in the Transition Zone”
- Ranjani Moorthi, MD, Indiana University
“The Use of Plant Based Diet to Treat Patients with Chronic Kidney-Disease-Mineral Bone Disorder”
About Satellite Healthcare
Satellite Healthcare, Inc., founded in 1973, is one of the nation’s first and leading providers of dialysis services and kidney disease care. With its affiliated services – Satellite WellBound, Satellite Dialysis and Satellite Research, Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows Satellite Healthcare to advance the standard of chronic kidney disease care so patients can achieve a better life.
Better care. Better life. Better choice.™
For more information about Satellite Healthcare and its mission to make life better for those with Chronic Kidney Disease, please visit www.SatelliteHealth.com.
Media Contact: Kim Hernandez, 650-404-3623